Geron
GERN
#6219
Rank
S$1.12 B
Marketcap
S$1.76
Share price
-2.16%
Change (1 day)
-66.64%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -S$60.87 Million

According to Geron's latest financial reports the company's current earnings are S$0.18 Billion. In 2024 the company made an earning of -S$0.21 Billion, an increase over its 2023 earnings that were of -S$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$60.87 Million-69.8%
2024 -S$0.21 Billion-11.23%
2023 -S$0.23 Billion30.22%
2022 -S$0.18 Billion20.15%
2021 -S$0.15 Billion50.08%
2020 -S$96.7 Million4.46%
2019 -S$92.57 Million130.68%
2018 -S$40.13 Million8.84%
2017 -S$36.87 Million-3.08%
2016 -S$38.04 Million-22080.6%
2015 S$0.17 M-100.38%
2014 -S$45.96 Million-7.14%
2013 -S$49.5 Million
2011 -S$0.12 Billion19.04%
2010 -S$98.37 Million8.45%
2009 -S$90.71 Million-2.51%
2008 -S$93.04 Million14.65%
2007 -S$81.16 Million32.68%
2006 -S$61.17 Million25.59%
2005 -S$48.7 Million4.36%
2004 -S$46.67 Million19.73%
2003 -S$38.98 Million-15.46%
2002 -S$46.11 Million1.94%
2001 -S$45.23 Million33.59%
2000 -S$33.86 Million27.53%
1999 -S$26.55 Million63.13%
1998 -S$16.28 Million15.6%
1997 -S$14.08 Million-10.66%
1996 -S$15.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-S$12.26 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.76 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.14 B-351.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$2.05 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-S$89.42 Million 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA